Microtubule-binding agents: a dynamic field of cancer therapeutics

Area of Science:

• Biochemistry
• Cell Biology
• Pharmacology

Background:

• Microtubules, composed of tubulin, are crucial cytoskeletal components and established therapeutic targets in cancer treatment.
• Anticancer agents targeting microtubules have a long history, serving as a key therapeutic strategy before the rise of targeted therapies.
• The search for novel microtubule-binding agents is driven by the need to overcome limitations of existing therapies.

Purpose of the Study:

• To identify and characterize novel agents that bind to microtubules.
• To explore botanical and marine sources for new antitubulin compounds with unique properties.
• To focus on developing agents with enhanced tumor specificity, reduced neurotoxicity, and insensitivity to chemoresistance.

Main Methods:

• Screening of diverse botanical species and marine organisms for antitubulin activity.
• Characterization of the binding properties and mechanisms of action of newly identified agents.
• Evaluation of tumor specificity, neurotoxicity, and efficacy against chemoresistant cancer cells.

Main Results:

• Identification of promising new antitubulin agents from botanical and marine sources.
• These novel agents exhibit unique properties and mechanisms of action.
• Preliminary data suggests potential for enhanced tumor specificity and reduced toxicity.

Conclusions:

• Botanical and marine natural products represent a rich source of novel microtubule-binding anticancer agents.
• The identified agents hold promise for overcoming current therapeutic challenges, including chemoresistance and toxicity.
• Further research is warranted to develop these compounds into clinically viable anticancer drugs.